Cargando…

Prescribed Versus Taken Polypharmacy and Drug–Drug Interactions in Older Cardiovascular Patients during the COVID-19 Pandemic: Observational Cross-Sectional Analytical Study

The study aimed to assess clinical pharmacology patterns of prescribed and taken medications in older cardiovascular patients using electronic health records (EHRs) (n = 704) (2019–2022). Medscape Drug Interaction Checker was used to identify pairwise drug–drug interactions (DDIs). Prevalence rates...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anfinogenova, Nina D., Novikova, Oksana M., Trubacheva, Irina A., Efimova, Elena V., Chesalov, Nazary P., Ussov, Wladimir Y., Maksimova, Aleksandra S., Shelkovnikova, Tatiana A., Ryumshina, Nadezhda I., Stepanov, Vadim A., Popov, Sergey V., Repin, Alexey N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420276/ https://www.ncbi.nlm.nih.gov/pubmed/37568464 http://dx.doi.org/10.3390/jcm12155061

Ejemplares similares

Transformative Effect of COVID-19 Pandemic on Magnetic Resonance Imaging Services in One Tertiary Cardiovascular Center
por: Shelkovnikova, Tatiana A., et al.
Publicado: (2023)

Use of contrast-enhanced MRI of the heart in detection of risk of supraventricular tachyarrhythmias in patients with recent myocardial infarction
por: Mochula, Olga, et al.
Publicado: (2015)

Existing and Emerging Approaches to Risk Assessment in Patients with Ascending Thoracic Aortic Dilatation
por: Anfinogenova, Nina D., et al.
Publicado: (2022)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

Prevalence of polypharmacy and risk of potential drug-drug interactions among hospitalized patients with emphasis on the pharmacokinetics
por: Georgiev, Kaloyan D., et al.
Publicado: (2022)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Targeting continuity of care and polypharmacy to reduce drug–drug interaction
por: Weng, Yi-An, et al.
Publicado: (2020)

Adverse drug reactions and polypharmacy in cardiac patients
por: Mugoša, Snežana, et al.
Publicado: (2012)

Polypharmacy - is there a cure for drug therapy problems?
por: Orehovački, Helena, et al.
Publicado: (2023)

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College
por: Khandeparkar, Akshay, et al.
Publicado: (2017)

Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
por: Dookeeram, Darren, et al.
Publicado: (2017)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

Contrast-enhanced MRI of aortal atherosclerosis: syndrome types and prediction of dissection
por: Maximova, Alexandra S, et al.
Publicado: (2015)

Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
por: Okoli, C, et al.
Publicado: (2020)

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
por: Rodrigues, Maria Cristina Soares, et al.
Publicado: (2016)

Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
por: Albertsen, Nadja, et al.
Publicado: (2022)

Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
por: Salamone, Sandro, et al.
Publicado: (2022)

Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
por: Kilit, Türkan Paşalı, et al.
Publicado: (2022)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2021)

The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
por: Nusair, Mohammad B., et al.
Publicado: (2020)

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
por: Guthrie, Bruce, et al.
Publicado: (2015)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
por: Krečak, Ivan, et al.
Publicado: (2023)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Drug information update. Unconventional treatment strategies for schizophrenia: polypharmacy and heroic dosing
por: Moore, Bret A., et al.
Publicado: (2017)

SimVec: predicting polypharmacy side effects for new drugs
por: Lukashina, Nina, et al.
Publicado: (2022)

Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk
por: Sienkiewicz, Kamila, et al.
Publicado: (2023)

Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study
por: Turner, R. M., et al.
Publicado: (2020)

Infective Endocarditis and Intravenous Drug Users: Never Was and Never Will Be Taken Lightly
por: Kansara, Tikal, et al.
Publicado: (2021)

Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender
por: Koh, Yvonne, et al.
Publicado: (2005)

Drug storage, polypharmacy and frailty syndrome in older people: an observational study
por: Tabué-Téguo, Maturin, et al.
Publicado: (2023)

Frequency of monocyte subsets is linked to the severity of atherosclerosis in patients with ischemic heart disease: A case-control study
por: Kologrivova, Irina, et al.
Publicado: (2020)

Using INTERCheck(®) to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
por: Martocchia, Antonio, et al.
Publicado: (2020)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
por: Sheikh-Taha, Marwan, et al.
Publicado: (2021)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
por: Hermann, Monica, et al.
Publicado: (2021)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study
por: Ayani, Nobutaka, et al.
Publicado: (2021)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
por: Farooq, Juveriya, et al.
Publicado: (2023)

Phosphoproteomics taken to heart
por: Lundby, Alicia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eh6du2t9nfnjcc2cn0i0e8kqeo